ghk cu recommended dosage subcutaneous injection GHK-Cu and Protocol: A Medical Provider's Guide to the 30-Day Cycle GHK-Cu Dosage Protocol Injection Guide
Description
Angiogenesis (new blood vessel formation): Research shows that TB500 promotes angiogenesis by enhancing endothelial cell migration, adhesion, and tube formation through its actin-binding motif

MOTS-c + Epitalon (Anti-Aging Stack) MOTS-c 5 mg once or twice per week for 8 to 12 weeks

Brandel, Jr
Ghrelin Receptor (GHS-R1a) Selective Activation Ipamorelin acts as a highly selective agonist of the growth hormone secretagogue receptor (GHS-R1a), mimicking the natural hormone ghrelin without affecting other pituitary hormone secretion: Selective binding to GHS-R1a receptors without stimulating ACTH, cortisol, or prolactin release Rapid onset of growth hormone pulse generation (peak levels within 40-60 minutes) No significant effect on appetite stimulation unlike other ghrelin mimetics Preserved feedback regulation through endogenous growth hormone-releasing inhibitory mechanisms Research indicates that ipamorelin releases growth hormone with potency and efficacy similar to GHRP-6 (EC50 approximately 1.3 nmol/L) but with superior selectivity for growth hormone secretion

Other treatment options have traditionally included surgical removal (excision), liquid nitrogen (freezing it off), curettage (scraping it off, often with electrical controlled burning), and lasering it off